KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2025)

Aurinia Pharmaceuticals' Tax Provisions history spans 6 years, with the latest figure at -$175.1 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 68298.44% year-over-year to -$175.1 million; the TTM value through Dec 2025 reached -$173.0 million, down 10302.89%, while the annual FY2025 figure was -$173.0 million, 10300.47% down from the prior year.
  • Tax Provisions reached -$175.1 million in Q4 2025 per AUPH's latest filing, down from $411000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.0 million in Q1 2025 to a low of -$175.1 million in Q4 2025.
  • Average Tax Provisions over 5 years is -$8.4 million, with a median of $423500.0 recorded in 2023.
  • Peak YoY movement for Tax Provisions: skyrocketed 11825.0% in 2022, then crashed 68298.44% in 2025.
  • A 5-year view of Tax Provisions shows it stood at $726000.0 in 2021, then rose by 17.77% to $855000.0 in 2022, then plummeted by 47.25% to $451000.0 in 2023, then tumbled by 156.76% to -$256000.0 in 2024, then plummeted by 68298.44% to -$175.1 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Tax Provisions are -$175.1 million (Q4 2025), $411000.0 (Q3 2025), and $643000.0 (Q2 2025).